Literature DB >> 32572906

LncRNA LINC00467 contributes to osteosarcoma growth and metastasis through regulating HMGA1 by directly targeting miR-217.

H-Z Ma1, J Wang, J Shi, W Zhang, D-S Zhou.   

Abstract

OBJECTIVE: Osteosarcoma (OS) is a common primary bone tumor. Despite multiple treatment strategies have made great progress, the overall clinical outcome of OS patients is frustrating. Long non-coding RNA (lncRNA) LINC00467 has been reported in several cancers, while the research of the role of LINC00467 in OS is limited. The aim of this study was to figure out the potential mechanism of LINC00467 in OS. PATIENTS AND METHODS: The expression levels of LINC00467, microRNA-217 (miR-217) and high mobility group A1 (HMGA1) were quantified by reverse transcription quantitative polymerase chain reaction (qRT-PCR). Cell counting kit-8 (CCK-8), flow cytometry and transwell assay were performed to detect cell proliferation, apoptosis, migration and invasion, respectively. The protein levels of HMGA1, B-cell lymphoma-2 (Bcl-2), Bax, Cleaved Caspase-3 (C-Caspase 3), E-cadherin, N-cadherin and vimentin were measured by Western blot assay. Online software starbase was used to predict the binding sites of miR-217. Luciferase report assay and RNA Binding Protein Immunoprecipitation (RIP) assay were carried out for detecting the interaction between miR-217 and LINC00467 or HMGA1.
RESULTS: The expression of LINC00467 and HMGA1 was increased in OS tissues and cells, while miR-217 expression was reduced. High expression of HMGA1 led to the poor overall survival. Down-regulation of LINC00467 or up-regulation of miR-217 could accelerate cell apoptosis, and slump cell proliferation, migration, invasion and EMT. However, miR-217 under-expression or HMGA1 over-expression could rescue these effects. Moreover, it was indicated that LINC00467 directly targeted miR-217 and HMGA1 was a target of miR-217.
CONCLUSIONS: LINC00467 promoted cell proliferation, migration, invasion and EMT, and suppressed cell apoptosis by up-regulating HMGA1 via targeting miR-217.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32572906     DOI: 10.26355/eurrev_202006_21486

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

1.  Paired Box 5-Induced LINC00467 Upregulation Promotes the Progression of Laryngeal Squamous Cell Cancer by Triggering the MicroRNA-4735-3p/TNF Alpha-Induced Protein 3 Pathway.

Authors:  Yuan Li; Yong Wu; Lili Dai; Honglin Wu; Chaohui Chen; Jiayu Ni; Enli Jin; Xuehua Zhou
Journal:  Mol Biotechnol       Date:  2022-10-10       Impact factor: 2.860

Review 2.  Long Noncoding RNA LINC00467: Role in Various Human Cancers.

Authors:  Di Wu; Rongfei Li; Jingyu Liu; Changcheng Zhou; Ruipeng Jia
Journal:  Front Genet       Date:  2022-06-01       Impact factor: 4.772

3.  HCP5 Promotes Proliferation and Contributes to Cisplatin Resistance in Gastric Cancer Through miR-519d/HMGA1 Axis.

Authors:  Zhu Zhang; Huahong Wang
Journal:  Cancer Manag Res       Date:  2021-01-27       Impact factor: 3.989

4.  Downregulated Reprimo by LINC00467 participates in the growth and metastasis of gastric cancer.

Authors:  Yuanyuan Wu; Juan Du
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 5.  LINC00467: an oncogenic long noncoding RNA.

Authors:  Xuyu Chen; Qian Luo; Yanan Xiao; Jing Zhu; Yirao Zhang; Jie Ding; Juan Li
Journal:  Cancer Cell Int       Date:  2022-10-07       Impact factor: 6.429

Review 6.  A review on the role of LINC00467 in the carcinogenesis.

Authors:  Soudeh Ghafouri-Fard; Tayyebeh Khoshbakht; Bashdar Mahmud Hussen; Mohammad Taheri; Mohammadreza Hajiesmaeili
Journal:  Cancer Cell Int       Date:  2022-10-13       Impact factor: 6.429

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.